Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Akorn Acquires U.S. Rights to Trio of Merck Eye Treatments
Akorn Acquires U.S. Rights to Trio of Merck Eye Treatments
Akorn Acquires U.S. Rights to Trio of Merck Eye Treatments
Submitted by
admin
on November 16, 2013 - 1:33pm
Source:
Motley Fool
News Tags:
Akorn
Merck
Azasite
Cosopt
Cosopt PF
Headline:
Akorn Acquires U.S. Rights to Trio of Merck Eye Treatments
Do Not Allow Advertisers to Use My Personal information
